PHOSPLATIN THERAPEUTICS LLC has a total of 45 patent applications. It increased the IP activity by 63.0%. Its first patent ever was published in 2013. It filed its patents most often in China, EPO (European Patent Office) and Taiwan. Its main competitors in its focus markets pharmaceuticals and organic fine chemistry are RR MEDSCIENCES PTY LTD, PLIVA LACHEMA AS and PLIVA LAKHEMA A S.
# | Country | Total Patents | |
---|---|---|---|
#1 | China | 5 | |
#2 | EPO (European Patent Office) | 5 | |
#3 | Taiwan | 5 | |
#4 | United States | 5 | |
#5 | WIPO (World Intellectual Property Organization) | 4 | |
#6 | Australia | 2 | |
#7 | Canada | 2 | |
#8 | Hungary | 2 | |
#9 | Republic of Korea | 2 | |
#10 | Serbia | 2 | |
#11 | Brazil | 1 | |
#12 | Chile | 1 | |
#13 | Colombia | 1 | |
#14 | Hong Kong | 1 | |
#15 | Israel | 1 | |
#16 | India | 1 | |
#17 | Mexico | 1 | |
#18 | Philippines | 1 | |
#19 | Singapore | 1 | |
#20 | Slovenia | 1 | |
#21 | South Africa | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Medical preparations | |
#3 | Special acyclic compounds |
# | Name | Total Patents |
---|---|---|
#1 | Luke Wayne D | 28 |
#2 | Ames Tyler | 26 |
#3 | Jost Steffen | 16 |
#4 | Price Matthew | 13 |
#5 | Tyler Ames | 2 |
#6 | Wayne D Luke | 2 |
#7 | Luke Wayne | 1 |
Publication | Filing date | Title |
---|---|---|
US2021121434A1 | Phosphaplatin Compounds as Immuno-Modulatory Agents and Therapeutic Uses Thereof | |
CN110381952A | It is used to treat the phosphorus platinum compounds of osteocarcinoma or leukemia as therapeutic agent | |
KR20180133889A | Formulated with phosphaplatin | |
WO2013176764A1 | Synthetic and purification methods for phosphaplatin compounds and uses thereof |